ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Accounts receivable, net

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.2B
P/E ratio
101.6x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 20268,179-1.08%
Mar 31, 20258,268+6.88%
Mar 31, 20247,736+2.93%
Mar 31, 20237,516-7.21%
Mar 31, 20228,100+1.53%
Mar 31, 20217,978+8.28%
Mar 31, 20207,368-7.47%
Mar 31, 20197,963-5.63%
Mar 31, 20188,438-14.65%
Mar 31, 20179,886-30.58%
Mar 31, 201614,241+11.28%
Mar 31, 201512,798

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat